Cargando…
Radiation recall dermatitis triggered by sorafenib after radiation therapy for hepatocellular carcinoma
Sorafenib is widely used for unresectable and metastatic hepatocellular carcinomas. Radiation recall dermatitis (RRD) is an acute inflammatory reaction confined to previously irradiated skin that occurs after the administration of certain drugs. RRD after sorafenib treatment is rare; five cases have...
Autores principales: | Kim, Gwi Eon, Song, Hee-Sung, Ahn, Ki Jung, Kim, Young Suk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Radiation Oncology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647756/ https://www.ncbi.nlm.nih.gov/pubmed/29037022 http://dx.doi.org/10.3857/roj.2017.00339 |
Ejemplares similares
-
Sorafenib-triggered radiation recall dermatitis with a disseminated exanthematous reaction
por: Oh, Dongryul, et al.
Publicado: (2013) -
Radiation recall dermatitis induced by tamoxifen during adjuvant breast cancer treatment
por: Rhee, Jiyoung, et al.
Publicado: (2014) -
Radiation Recall Dermatitis in Patients Treated with Sorafenib
por: Mehta, Keyur, et al.
Publicado: (2018) -
Recall radiation dermatitis by sorafenib following stereotactic body radiation therapy
por: Hsieh, Chen-Hsi, et al.
Publicado: (2014) -
Mechanism of enhancement of radiation-induced cytotoxicity by sorafenib in colorectal cancer
por: Kim, Yong Bae, et al.
Publicado: (2013)